The discovery of GDF10 as a HSC-derived factor capable of attenuating liver fibrosis through dual modulation of TGF-β signaling and metabolic reprogramming represents a significant advancement in our understanding of antifibrotic mechanisms. The gene discussed is TGFB1; the disease is Hepatic fibrosis.